Next generation sequencing identifies novel PMPCA variants in patients with dominant optic atrophy - Archive ouverte HAL Access content directly
Journal Articles Genes Year : 2022

Next generation sequencing identifies novel PMPCA variants in patients with dominant optic atrophy

Majida Charif
Selma Kane
  • Function : Author

Abstract

Dominant Optic Atrophy (DOA) is one of the most common inherited mitochondrial diseases, leading to blindness. It is caused by the chronic degeneration of the retinal ganglion cells (RGCs) and their axons forming the optic nerve. Until now, DOA has been mainly associated with genes encoding proteins involved in mitochondrial network dynamics. Using next-generation and exome sequencing, we identified for the first time heterozygous PMPCA variants having a causative role in the pathology of late-onset primary DOA in five patients. PMPCA encodes an α subunit of the mitochondrial peptidase (MPP), responsible for the cleavage and maturation of the mitochondrial precursor proteins imported from the cytoplasm into mitochondria. Recently, PMPCA has been identified as the gene responsible for Autosomal Recessive Cerebellar Ataxia type 2 (SCAR2) and another severe recessive mitochondrial disease. In this study, four PMPCA variants were identified, two are frameshifts (c.309delA and c.820delG) classified as pathogenic and two are missenses (c.1363G>A and c.1547G>A) classified with uncertain pathological significance. Functional assays on patients’ fibroblasts show a hyperconnection of the mitochondrial network and revealed that frameshift variants reduced α-MPP levels, while not significantly affecting the respiratory machinery. These results suggest that alterations in mitochondrial peptidase function can affect the fusion-fission balance, a key element in maintaining the physiology of retinal ganglion cells, and consequently lead to their progressive degeneration.
Fichier principal
Vignette du fichier
GENEJOURNAL-S-21-00887 (2).pdf (1.95 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03861086 , version 1 (19-11-2022)

Identifiers

Cite

Majida Charif, Arnaud Chevrollier, Naïg Gueguen, Selma Kane, Céline Bris, et al.. Next generation sequencing identifies novel PMPCA variants in patients with dominant optic atrophy. Genes, 2022, 13 (7), pp.1202. ⟨10.3390/genes13071202⟩. ⟨hal-03861086⟩
20 View
37 Download

Altmetric

Share

Gmail Facebook X LinkedIn More